Bock, Felix, Onderka, Jasmine, Braun, Gabriele, Schneider, Ann-Charlott, Hos, Deniz, Bi, Yanlong, Bachmann, Bjoern O. and Cursiefen, Claus (2016). Identification of Novel Endogenous Anti(lymph)angiogenic Factors in the Aqueous Humor. Invest. Ophthalmol. Vis. Sci., 57 (15). S. 6554 - 6561. ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC. ISSN 1552-5783

Full text not available from this repository.

Abstract

PURPOSE. The avascular cornea is in direct contact with aqueous humor (AqH). Here we investigate whether AqH exerts anti(lymph) angiogenic effects and thereby may contribute to corneal (lymph) angiogenic privilege. METHODS. Using the murine model of suture-induced inflammatory corneal hem-and lymphangiogenesis, the potential anti(lymph) angiogenic effect of AqH was analyzed by applying murine AqH as eyedrops. Anti(lymph) angiogenic effects were measured using morphometric analysis of flat mounts stained with CD31 as panendothelial and LYVE-1 as specific lymphatic endothelial marker. The potential antilymphangiogenic effect of immunomodulatory factors contained in AqH such as vasoactive intestinal peptide (VIP) and alpha-melanocyte stimulating hormone (alpha-MSH) was analyzed in lymphatic and blood vascular endothelial cell proliferation assays in vitro. RESULTS. Topically applied AqH significantly inhibited corneal hemangiogenesis and even more so lymphangiogenesis in vivo and directly in vitro. The immunoregulatory factors VIP and alpha-MSH significantly inhibited lymphatic endothelial cell proliferation in vitro. Depletion of VIP or alpha-MSH from AqH diminished its anti-hem-and lymphangiogenic potential. CONCLUSIONS. Aqueous humor exerts significant antilymphangiogenic effects in vivo. This is at least partially mediated by the known immunomodulatory factors VIP and alpha-MSH present in the AqH. Therefore, AqH not only contributes to corneal lymphangiogenic privilege and is a new tool to identify novel endogenous regulators of lymphangiogenesis but also may have therapeutic applications.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Bock, FelixUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Onderka, JasmineUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Braun, GabrieleUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schneider, Ann-CharlottUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hos, DenizUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bi, YanlongUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bachmann, Bjoern O.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Cursiefen, ClausUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-253647
DOI: 10.1167/iovs.15-18526
Journal or Publication Title: Invest. Ophthalmol. Vis. Sci.
Volume: 57
Number: 15
Page Range: S. 6554 - 6561
Date: 2016
Publisher: ASSOC RESEARCH VISION OPHTHALMOLOGY INC
Place of Publication: ROCKVILLE
ISSN: 1552-5783
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
MELANOCYTE-STIMULATING HORMONE; GROWTH-FACTOR-BETA; IMMUNOSUPPRESSIVE FACTOR; CARCINOMA-CELLS; CORNEAL; LYMPHANGIOGENESIS; NEOVASCULARIZATION; HEMANGIOGENESIS; ANGIOGENESIS; INHIBITIONMultiple languages
OphthalmologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/25364

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item